Day: April 16, 2024

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

Written by Customer Service on April 16, 2024. Posted in Earnings Releases And Operating Results.

Q4 revenue of $28.4 million, increasing 44% year-over-year Q4 gross profit increased 43% year-over-year to $17.8 million with gross margins coming in at 63% for both periods Acquired Healthy Offers, Inc. (dba Medicx Health), a leading healthcare consumer-focused omnichannel marketing and analytics company that significantly expands our footprint with consumers and patients Meaningfully increased our DAAP footprint: 24 DAAP deals in 2023 compared to six deals in 2022WALTHAM, Mass., April 16, 2024 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, reported results for the fourth quarter and full year ended December 31, 2023. Twelve Months Ended December 31,Key...

Guardian Capital Announces April 2024 Cash Distributions for Guardian Capital ETFs

Written by Customer Service on April 16, 2024. Posted in Dividend Reports And Estimates.

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the period ending April 30, 2024, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on April 30, 2024 to unitholders of record on April 24, 2024. The ex-dividend date in each case is anticipated to be April 23, 2024, with the exception of Guardian Ultra-Short Canadian T-Bill Fund and Guardian Ultra-Short U.S. T-Bill Fund which are money market funds and which are anticipated to have an ex-dividend date of April 24, 2024.Guardian Capital ETFs Series of ETFUnits DistributionFrequency TradingSymbol Exchange Distribution Amount(per ETF Unit)Guardian Directed Equity Path Portfolio Hedged ETF Units Monthly GDEP TSX CAD$0.0770Guardian...

Truth Social to Launch Streaming Platform

Written by Customer Service on April 16, 2024. Posted in Public Companies.

TMTG finishes R&D on its own content delivery network, announcing plans for phased streaming introduction SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) — Trump Media & Technology Group Corp. (NASDAQ:DJT) (“TMTG” or the “Company”), operator of the social media platform Truth Social, announced today that after six months of testing on its Web and iOS platforms, the Company has finished the research and development phase of its new live TV streaming platform and will begin scaling up its own content delivery network (“CDN”). TMTG plans to roll out its streaming content in three phases:Phase 1: Introduce Truth Social’s CDN for streaming live TV to the Truth Social app for Android, iOS, and Web. Phase 2: Release stand-alone Truth Social over-the-top (“OTT”) streaming apps for phones, tablets, and other devices. Phase 3:...

TC Energy to issue first quarter 2024 results on May 3 and hold annual and special meeting of common shareholders on June 4

Written by Customer Service on April 16, 2024. Posted in Public Companies.

CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) will release its first quarter 2024 financial results on Friday, May 3, 2024 pre-market and hold its 2024 annual and special meeting of common shareholders on Tuesday, June 4, 2024, at 8 a.m. MDT / 10 a.m. EDT. First quarter 2024 financial resultsFrançois Poirier, TC Energy President and Chief Executive Officer, Joel Hunter, Executive Vice-President and Chief Financial Officer and other members of the executive leadership team will discuss the financial results and Company developments at 6:30 a.m. MDT / 8:30 a.m. EDT. Members of the investment community and other interested parties are invited to participate by calling 1-844-763-8274 (Canada/U.S.) or 1-647-484-8814 (International). No passcode is required. Please...

SAB Biotherapeutics Provides SAB-142 Trial Update

Written by Customer Service on April 16, 2024. Posted in Public Companies.

MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced their Chief Medical Officer, Dr. Alexandra Kropotova, MD, MBA disclosed that SAB has completed dosing the third cohort for SAB-142 with no observation of serum sickness thus far. In October 2023, SAB received approval by the Australian Human Research Ethics Committee (HREC) to commence the Phase 1 clinical trial investigating safety, tolerability, pharmacokinetic, pharmacodynamic, and immunogenicity of SAB-142. The primary objective of the trial is two-fold: 1) to generate data on differentiated...

St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

Written by Customer Service on April 16, 2024. Posted in Public Companies.

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from St. Michael’s Hospital, a site of Unity Health Toronto, has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). LSALT peptide is the Company’s lead drug candidate for preventing and treating inflammation injury in the kidneys, lungs and liver. “Our research team is excited to be participating in this trial. Organ injury and repair is a Unity Health Toronto Research Pillar, and we are committed to investigating key mechanisms underlying tissue injury and healing, and to developing therapies to reduce injury and enhance regeneration,” said Dr. David Mazer, translational researcher,...

Hut 8 optimizes self-mining operations as miners come online at Salt Creek

Written by Customer Service on April 16, 2024. Posted in Public Companies.

Greenfield site energized in 78 days, less than three months after breaking ground Cost to mine a Bitcoin at site expected to be 30% lower than cost at hosted facilities due to favorable energy profile MIAMI, April 16, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, today announced the energization of one third of its 63 MW site in Culberson County, Texas (“Salt Creek”). Hut 8 is phasing energization to maximize deployed hashrate pre-halving and will continue to energize the site in the coming weeks. “With Salt Creek, we gain critical control over our miner fleet and operating costs as we head into the halving,” said Asher Genoot, CEO of Hut 8. “Our outlook on energy...

Goodfood Reports Second Quarter Results Including $40 million of Net Sales, $1.4 million of Net Income and $3.5 million of Adjusted EBITDA¹

Written by Customer Service on April 16, 2024. Posted in Earnings Releases And Operating Results.

Net sales were $40 million in the second quarter, a 5% reduction compared to the same quarter last year and flat compared to the first quarter of Fiscal 2024 Gross margin increased to record 43.0% for the quarter, an improvement of 2.3% quarter-over-quarter, with gross profit at $17 million Net income for the quarter was $1.4 million, a $1.3 million improvement compared to the same quarter last year Adjusted EBITDA margin1 of 8.9% for an adjusted EBITDA1 of $3.5 million this quarter, a $0.5 million improvement compared to the same quarter last year Cash flows provided by operations were $0.1 million for the quarter, an improvement of $4.5 million compared to the same quarter last year, reaching $3.9 million year-to-date Adjusted free cash flow1 was $0.3 million for the quarter, a $2.5 million improvement compared to the same quarter last...

Multitude SE – Managers’ transactions – Tiukkanen

Written by Customer Service on April 16, 2024. Posted in Public Companies.

Multitude SE – Managers’ transactions – Tiukkanen ____________________________________________ Person subject to the notification requirementName: Tiukkanen, AriPosition: Other senior managerIssuer: Multitude SELEI: 74370078YLPFWHE33716 Notification type: INITIAL NOTIFICATIONReference number: 74370078YLPFWHE33716_20240416104440_136____________________________________________ Transaction date: 2024-04-15Venue not applicableInstrument type: SHAREISIN: FI4000106299Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 319 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 319 Volume weighted average price: 0.00 EUR

Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement

Written by Customer Service on April 16, 2024. Posted in Public Companies.

Financing includes new and existing leading life sciences institutional investors Proceeds, along with existing cash and cash equivalents, are expected to extend cash runway into 2028 Cullinan to host a virtual investor event on April 16 at 8:00 am ET CAMBRIDGE, Mass., April 16, 2024 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that it has entered into a stock purchase agreement with certain institutional and accredited investors for a private placement of approximately $274.0 million of shares of its common stock at a price of $19.00 per share and, in lieu of common stock to certain investors, $6.0 million of pre-funded warrants to purchase shares of its common...

Day: April 16, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals